Morgan Stanley’s ClearPoint Neuro CLPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.97M | Buy |
332,323
+174,353
| +110% | +$2.08M | ﹤0.01% | 4241 |
|
2025
Q1 | $1.88M | Buy |
157,970
+73,631
| +87% | +$875K | ﹤0.01% | 4642 |
|
2024
Q4 | $1.3M | Buy |
84,339
+37,512
| +80% | +$577K | ﹤0.01% | 4953 |
|
2024
Q3 | $525K | Sell |
46,827
-43,372
| -48% | -$486K | ﹤0.01% | 5381 |
|
2024
Q2 | $486K | Sell |
90,199
-63,752
| -41% | -$344K | ﹤0.01% | 5309 |
|
2024
Q1 | $1.05M | Sell |
153,951
-170,027
| -52% | -$1.16M | ﹤0.01% | 4930 |
|
2023
Q4 | $2.2M | Buy |
323,978
+205,284
| +173% | +$1.39M | ﹤0.01% | 4873 |
|
2023
Q3 | $595K | Buy |
118,694
+49,156
| +71% | +$246K | ﹤0.01% | 5090 |
|
2023
Q2 | $503K | Sell |
69,538
-25,803
| -27% | -$187K | ﹤0.01% | 5207 |
|
2023
Q1 | $805K | Buy |
95,341
+1,754
| +2% | +$14.8K | ﹤0.01% | 4983 |
|
2022
Q4 | $793K | Sell |
93,587
-10,077
| -10% | -$85.4K | ﹤0.01% | 4991 |
|
2022
Q3 | $1.07M | Sell |
103,664
-24,047
| -19% | -$249K | ﹤0.01% | 4842 |
|
2022
Q2 | $1.67M | Sell |
127,711
-49,001
| -28% | -$639K | ﹤0.01% | 4670 |
|
2022
Q1 | $1.84M | Buy |
176,712
+50,416
| +40% | +$525K | ﹤0.01% | 4579 |
|
2021
Q4 | $1.42M | Buy |
126,296
+113,360
| +876% | +$1.27M | ﹤0.01% | 4835 |
|
2021
Q3 | $230K | Sell |
12,936
-18,641
| -59% | -$331K | ﹤0.01% | 5924 |
|
2021
Q2 | $603K | Sell |
31,577
-36,097
| -53% | -$689K | ﹤0.01% | 5407 |
|
2021
Q1 | $1.43M | Buy |
67,674
+59,641
| +742% | +$1.26M | ﹤0.01% | 4500 |
|
2020
Q4 | $127K | Buy |
8,033
+7,033
| +703% | +$111K | ﹤0.01% | 5809 |
|
2020
Q3 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 6436 |
|
2020
Q2 | – | Sell |
-500
| Closed | -$2K | – | 6612 |
|
2020
Q1 | $2K | Hold |
500
| – | – | ﹤0.01% | 6374 |
|
2019
Q4 | $2K | Sell |
500
-1,054
| -68% | -$4.22K | ﹤0.01% | 6493 |
|
2019
Q3 | $8K | Buy |
+1,554
| New | +$8K | ﹤0.01% | 6266 |
|